Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Клинические результаты эндоваскулярной реваскуляризации в госпитальном периоде инфаркта миокарда без Q-зубца с использованием стентов с лекарственным покрытием
Клинические результаты эндоваскулярной реваскуляризации в госпитальном периоде инфаркта миокарда без Q-зубца с использованием стентов с лекарственным покрытием
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Kao W, Khaja F, Goldstein S. Cardiac event rate after non-Q-wave acute myocardial infarction and the significance of its anterior location. Am J Cardiol 1989; 64: 1236–42.
2. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. N Engl J Med 1989; 320:618: 627.
3. Early invasive versus conservative strategy in non-Q-MI. VANQWISH TRIAL. N Engl Med 1998; 338: 1785–92.
4. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology. Ryan TJ, Faxon DD, Gunnar RM. J Am Coll Cardiol 1988; 12: 529.
5. Matetzky S, Barabash GI, Rabinowitz B. Q-wave and non-Q-wave myocardial infarction after thrombolysis. J Am Coll Cardiol 1995; 26: 1445–51.
6. Yan AT, Tan M. One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry). Am J Cardiol 2005; 95: 438.
7. Early invasive versus conservative strategy for acute coronary syndroms. TACTICS-TIMI 18. N Engl J Med 2001; 344: 1879–87.
8. Early invasive versus conservative strategy in unstable angina and non-Q-MI. FRISC I study. Lancet 1999; 354: 708–15.
9. Early invasive versus conservative strategy in unstable angina and non-Q-MI. FRISC II 1 year study. Lancet 2000; 356: 9–16.
10. Early invasive versus conservative strategy in non-ST elevation MI. MITI registry. J Am Coll Cardiol 2000; 35: 895–902.
11. Madsen S. et al. Invasive versus conservative strategy for ischemia after acute MI. DANAMI trial. Circulation 1997; 96: 748–55.
12. Colombo A, Fajadet J, Schuler G. 365-day follow-up of the RAVEL study: a randomized study with sirolimus-eluting BX Velocity balloon-expandable stent. Eur Heart J 2002; 4 (Suppl. A): 264.
13. Morice M-C, Serruys PW, Sousa JE et al. A randomized comparison of a sirolimus-eluting stent with a standart stent for coronary revascularization. N Engl J Med 2002; 346: 1773–80.
14. Ivanhoe RJ et al. Percutaneous transluminal coronary angioplasty of chronic total occlusions. Primary success, restenosis and long-term clinical follow-up. Circulation 1992; 85: 106–15.
15. Bell MR et al. Initial and long-term outcome of 354 patients after coronary balloon angioplasty of total coronary occlusion. Circulation 1992; 85: 1003–11.
16. Olivari Z et al. Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions J Am Coll Cardiol 2003; 41: 1672–8.
17. Sirnes PA, Golf S, Myreng Y. Stenting in Chronic Coronary Occlusion (SICCO): a randomized controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996; 28: 1444–51.
18. Rubartelli P, Niccoli L, Verna E et al. Stent implantation versus balloon angioplasty in chronic coronary occlusions: results from the GISSOS trial. J Am Coll Cardiol 1998; 32: 90–6.
19. Suero JA, Marso SP, Jones PG et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: A 20-year experience. J Am Coll Cardiol 2001; 38: 409–14.
2. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. N Engl J Med 1989; 320:618: 627.
3. Early invasive versus conservative strategy in non-Q-MI. VANQWISH TRIAL. N Engl Med 1998; 338: 1785–92.
4. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology. Ryan TJ, Faxon DD, Gunnar RM. J Am Coll Cardiol 1988; 12: 529.
5. Matetzky S, Barabash GI, Rabinowitz B. Q-wave and non-Q-wave myocardial infarction after thrombolysis. J Am Coll Cardiol 1995; 26: 1445–51.
6. Yan AT, Tan M. One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry). Am J Cardiol 2005; 95: 438.
7. Early invasive versus conservative strategy for acute coronary syndroms. TACTICS-TIMI 18. N Engl J Med 2001; 344: 1879–87.
8. Early invasive versus conservative strategy in unstable angina and non-Q-MI. FRISC I study. Lancet 1999; 354: 708–15.
9. Early invasive versus conservative strategy in unstable angina and non-Q-MI. FRISC II 1 year study. Lancet 2000; 356: 9–16.
10. Early invasive versus conservative strategy in non-ST elevation MI. MITI registry. J Am Coll Cardiol 2000; 35: 895–902.
11. Madsen S. et al. Invasive versus conservative strategy for ischemia after acute MI. DANAMI trial. Circulation 1997; 96: 748–55.
12. Colombo A, Fajadet J, Schuler G. 365-day follow-up of the RAVEL study: a randomized study with sirolimus-eluting BX Velocity balloon-expandable stent. Eur Heart J 2002; 4 (Suppl. A): 264.
13. Morice M-C, Serruys PW, Sousa JE et al. A randomized comparison of a sirolimus-eluting stent with a standart stent for coronary revascularization. N Engl J Med 2002; 346: 1773–80.
14. Ivanhoe RJ et al. Percutaneous transluminal coronary angioplasty of chronic total occlusions. Primary success, restenosis and long-term clinical follow-up. Circulation 1992; 85: 106–15.
15. Bell MR et al. Initial and long-term outcome of 354 patients after coronary balloon angioplasty of total coronary occlusion. Circulation 1992; 85: 1003–11.
16. Olivari Z et al. Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions J Am Coll Cardiol 2003; 41: 1672–8.
17. Sirnes PA, Golf S, Myreng Y. Stenting in Chronic Coronary Occlusion (SICCO): a randomized controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996; 28: 1444–51.
18. Rubartelli P, Niccoli L, Verna E et al. Stent implantation versus balloon angioplasty in chronic coronary occlusions: results from the GISSOS trial. J Am Coll Cardiol 1998; 32: 90–6.
19. Suero JA, Marso SP, Jones PG et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: A 20-year experience. J Am Coll Cardiol 2001; 38: 409–14.
Авторы
А.П.Савченко1, П.А.Болотов2, О.В.Черкавская1, Б.А.Руденко1
1 Институт клинической кардиологии им. А.Л.Мясникова РКНПК Минздравсоцразвития РФ;
2 Центральный клинический военный госпиталь ФСБ РФ
1 Институт клинической кардиологии им. А.Л.Мясникова РКНПК Минздравсоцразвития РФ;
2 Центральный клинический военный госпиталь ФСБ РФ
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.